Pay vs Performance Disclosure
|
12 Months Ended |
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Pay vs Performance [Table Text Block] |
|
Pay Versus Performance Disclosure
In accordance with rules adopted by the Securities and Exchange
Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are providing the following disclosure
regarding executive compensation for our principal executive officer (“PEO”) and Non-PEO NEOs and Company performance
for the fiscal years listed below. The Compensation Committee did not consider the pay versus performance disclosure below in making
its pay decisions for any of the years shown.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Value of Initial Fixed $100 Investment based on(4) |
|
|
|
|
Year |
|
Summary
Compensation
Table Total for
Chirag Patel(1)
($) |
|
Summary
Compensation
Table Total for
Chintu Patel(1)
($) |
|
Compensation
Actually Paid
to Chirag
Patel(1)(2)(3)
($) |
|
Compensation
Actually Paid
to Chintu
Patel(1)(2)(3)
($) |
|
Average
Summary
Compensation
Table Total
for Non-PEO
NEOs(1)
($) |
|
Average
Compensation
Actually Paid
to Non-PEO
NEOs(1)(2)(3)
($) |
|
TSR
($) |
|
Peer
Group
TSR
($) |
|
Net
Income
($ Millions) |
|
Adjusted
EBITDA
($ Millions)(5) |
(a) |
|
(b) |
|
(b) |
|
(c) |
|
(c) |
|
(d) |
|
(e) |
|
(f) |
|
(g) |
|
(h) |
|
(i) |
2022 |
|
5,048,110 |
|
5,062,732 |
|
(1,835,706) |
|
(1,821,083) |
|
2,348,670 |
|
(121,995) |
|
41.29 |
|
123.43 |
|
(255) |
|
514 |
2021 |
|
4,785,116 |
|
4,798,825 |
|
1,383,918 |
|
1,397,627 |
|
2,420,041 |
|
1,421,310 |
|
99.38 |
|
129.31 |
|
20 |
|
538 |
2020 |
|
2,320,716 |
|
2,328,528 |
|
3,422,575 |
|
3,430,387 |
|
1,922,858 |
|
1,985,608 |
|
94.81 |
|
114.32 |
|
69 |
|
433 |
(1) |
Chirag Patel and Chintu Patel were our Co-PEOs for each year presented. The individuals comprising
the Non-PEO NEOs for each year presented are listed below. |
2020 |
2021 |
2022 |
Andrew Boyer |
Andrew Boyer |
Andrew Boyer |
Anastasios Konidaris |
Anastasios Konidaris |
Anastasios Konidaris |
Nikita Shah |
Nikita Shah |
Nikita Shah |
Joseph Todisco |
Joseph Todisco |
Jason Daly |
Todd Branning |
|
|
(2) |
The amounts shown for Compensation Actually Paid have been calculated in accordance
with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company’s
NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below. |
(3) |
Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the
PEOs and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts
in the Exclusion of Stock Awards column are the amounts from the Stock Awards column set forth in the Summary Compensation
Table. |
Year |
|
Summary Compensation
Table Total for Chirag
Patel
($) |
|
Exclusion of Stock
Awards for Chirag Patel
($) |
|
Inclusion of Equity
Values for Chirag Patel
($) |
|
Compensation Actually
Paid to Chirag Patel
($) |
2022 |
|
5,048,110 |
|
(3,605,796) |
|
(3,278,019) |
|
(1,835,706) |
2021 |
|
4,785,116 |
|
(3,266,406) |
|
(134,792) |
|
1,383,918 |
2020 |
|
2,320,716 |
|
(2,298,679) |
|
3,400,538 |
|
3,422,575 |
Year |
|
Summary Compensation
Table Total for Chintu
Patel
($) |
|
Exclusion of Stock
Awards for Chintu Patel
($) |
|
Inclusion of Equity
Values for Chintu Patel
($) |
|
Compensation Actually
Paid to Chintu Patel
($) |
2022 |
|
5,062,732 |
|
(3,605,796) |
|
(3,278,019) |
|
(1,821,083) |
2021 |
|
4,798,825 |
|
(3,266,406) |
|
(134,792) |
|
1,397,627 |
2020 |
|
2,328,528 |
|
(2,298,679) |
|
3,400,538 |
|
3,430,387 |
Year |
|
Average Summary
Compensation Table
Total for Non-PEO NEOs
($) |
|
Average Exclusion
of Stock Awards and
Option Awards for Non-
PEO NEOs
($) |
|
Average Inclusion of
Equity Values for Non-
PEO NEOs
($) |
|
Average Compensation
Actually Paid to Non-
PEO NEOs
($) |
2022 |
|
2,348,670 |
|
(1,485,810) |
|
(984,855) |
|
(121,995) |
2021 |
|
2,420,041 |
|
(1,505,143) |
|
506,412 |
|
1,421,310 |
2020 |
|
1,922,858 |
|
(1,108,402) |
|
1,171,151 |
|
1,985,608 |
The amounts in the Inclusion of Equity Values in the tables
above are derived from the amounts set forth in the following tables:
Year |
|
Year-End Fair Value
of Equity Awards
Granted During
Year That Remained
Unvested as of
Last Day of Year for
Chirag Patel
($) |
|
Change in Fair
Value from Last
Day of Prior Year
to Last Day of Year
of Unvested Equity
Awards for Chirag
Patel
($) |
|
Change in Fair Value
from Last Day of
Prior Year to Vesting
Date of Unvested
Equity Awards that
Vested During Year
for Chirag Patel
($) |
|
Fair Value at Last
Day of Prior Year
of Equity Awards
Forfeited During
Year for Chirag Patel
($) |
|
Total - Inclusion of
Equity Values for
Chirag Patel
($) |
2022 |
|
— |
|
(3,278,019) |
|
— |
|
— |
|
(3,278,019) |
2021 |
|
2,385,096 |
|
(2,519,888) |
|
— |
|
— |
|
(134,792) |
2020 |
|
3,430,708 |
|
— |
|
(30,170) |
|
— |
|
3,400,538 |
|
|
|
|
|
|
|
|
|
|
|
Year |
|
Year-End Fair Value
of Equity Awards
Granted During
Year That Remained
Outstanding and
Unvested as of
Last Day of Year for
Chintu Patel
($) |
|
Change in Fair
Value from Last
Day of Prior Year
to Last Day of Year
of Unvested Equity
Awards for Chintu
Patel
($) |
|
Change in Fair Value
from Last Day of
Prior Year to Vesting
Date of Unvested
Equity Awards that
Vested During Year
for Chintu Patel
($) |
|
Fair Value at Last
Day of Prior Year
of Equity Awards
Forfeited During
Year for Chintu Patel
($) |
|
Total - Inclusion of
Equity Values for
Chintu Patel
($) |
2022 |
|
— |
|
(3,278,019) |
|
— |
|
— |
|
(3,278,019) |
2021 |
|
2,385,096 |
|
(2,519,888) |
|
— |
|
— |
|
(134,792) |
2020 |
|
3,430,708 |
|
— |
|
(30,170) |
|
— |
|
3,400,538 |
|
|
|
|
|
|
|
|
|
|
|
Year |
|
Average Year-
End Fair Value of
Equity Awards
Granted During
Year That Remained
Outstanding and
Unvested as of Last
Day of Year for Non-
PEO NEOs
($) |
|
Average Change in
Fair Value from Last
Day of Prior Year
to Last Day of Year
of Unvested Equity
Awards for Non-PEO
NEOs
($) |
|
Average Change in
Fair Value from Last
Day of Prior Year
to Vesting Date of
Unvested Equity
Awards that Vested
During Year for Non-
PEO NEOs
($) |
|
Average Fair Value
at Last Day of
Prior Year of Equity
Awards Forfeited
During Year for Non-
PEO NEOs
($) |
|
Total - Average
Inclusion of
Equity Values for
Non-PEO NEOs
($) |
2022 |
|
285,402 |
|
(1,195,845) |
|
(74,412) |
|
— |
|
(984,855) |
2021 |
|
1,086,401 |
|
(581,373) |
|
81,828 |
|
(80,444) |
|
506,412 |
2020 |
|
1,410,331 |
|
(56,431) |
|
(50,813) |
|
(131,936) |
|
1,171,151 |
(4) |
The Peer Group TSR set forth in this table utilizes the Dow Jones U.S. Select Pharmaceuticals Index,
which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K, included in our Annual Report
for the year ended December 31, 2022. The comparison assumes $100 was invested for the period starting December 31, 2019 (The
last trading day of fiscal 2019), through the end of the listed year in the Company and in the Dow Jones U.S. Select Pharmaceuticals
Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. |
(5) |
We determined Adjusted EBITDA to be the most important financial performance measure used to link Company performance
to Compensation Actually Paid to our PEOs and Non-PEO NEOs in 2022. This performance measure may not have been the most important
financial performance measure for years 2021 and 2020, and we may determine a different financial performance measure to be
the most important financial performance measure in future years. Adjusted EBITDA is not a term defined under U.S. GAAP. We
define adjusted EBITDA as net income before net interest expense, income taxes, and depreciation and amortization (“EBITDA”),
as adjusted for certain other items described in our SEC filings, including stock-based compensation expense, acquisition,
site closure and idle facility expenses, restructuring and other charges, net charges related to legal matters, asset impairment
charges, foreign exchange losses or gains, change in fair value of contingent consideration, and insurance recoveries for
property losses and associated expenses. Prior to January 1, 2022, research and development milestone expenses related to
license and collaboration agreements were excluded from our calculation of adjusted EBITDA. The amounts shown in this column
for the fiscal years ended December 31, 2021 and December 31, 2020 reflect this historical |
|
|
|
Named Executive Officers, Footnote [Text Block] |
|
(1) |
Chirag Patel and Chintu Patel were our Co-PEOs for each year presented. The individuals comprising
the Non-PEO NEOs for each year presented are listed below. |
2020 |
2021 |
2022 |
Andrew Boyer |
Andrew Boyer |
Andrew Boyer |
Anastasios Konidaris |
Anastasios Konidaris |
Anastasios Konidaris |
Nikita Shah |
Nikita Shah |
Nikita Shah |
Joseph Todisco |
Joseph Todisco |
Jason Daly |
Todd Branning |
|
|
|
|
|
Peer Group Issuers, Footnote [Text Block] |
|
The Peer Group TSR set forth in this table utilizes the Dow Jones U.S. Select Pharmaceuticals Index,
which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K, included in our Annual Report
for the year ended December 31, 2022. The comparison assumes $100 was invested for the period starting December 31, 2019 (The
last trading day of fiscal 2019), through the end of the listed year in the Company and in the Dow Jones U.S. Select Pharmaceuticals
Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
|
|
|
Adjustment To PEO Compensation, Footnote [Text Block] |
|
Year |
|
Summary Compensation
Table Total for Chirag
Patel
($) |
|
Exclusion of Stock
Awards for Chirag Patel
($) |
|
Inclusion of Equity
Values for Chirag Patel
($) |
|
Compensation Actually
Paid to Chirag Patel
($) |
2022 |
|
5,048,110 |
|
(3,605,796) |
|
(3,278,019) |
|
(1,835,706) |
2021 |
|
4,785,116 |
|
(3,266,406) |
|
(134,792) |
|
1,383,918 |
2020 |
|
2,320,716 |
|
(2,298,679) |
|
3,400,538 |
|
3,422,575 |
Year |
|
Summary Compensation
Table Total for Chintu
Patel
($) |
|
Exclusion of Stock
Awards for Chintu Patel
($) |
|
Inclusion of Equity
Values for Chintu Patel
($) |
|
Compensation Actually
Paid to Chintu Patel
($) |
2022 |
|
5,062,732 |
|
(3,605,796) |
|
(3,278,019) |
|
(1,821,083) |
2021 |
|
4,798,825 |
|
(3,266,406) |
|
(134,792) |
|
1,397,627 |
2020 |
|
2,328,528 |
|
(2,298,679) |
|
3,400,538 |
|
3,430,387 |
Year |
|
Year-End Fair Value
of Equity Awards
Granted During
Year That Remained
Unvested as of
Last Day of Year for
Chirag Patel
($) |
|
Change in Fair
Value from Last
Day of Prior Year
to Last Day of Year
of Unvested Equity
Awards for Chirag
Patel
($) |
|
Change in Fair Value
from Last Day of
Prior Year to Vesting
Date of Unvested
Equity Awards that
Vested During Year
for Chirag Patel
($) |
|
Fair Value at Last
Day of Prior Year
of Equity Awards
Forfeited During
Year for Chirag Patel
($) |
|
Total - Inclusion of
Equity Values for
Chirag Patel
($) |
2022 |
|
— |
|
(3,278,019) |
|
— |
|
— |
|
(3,278,019) |
2021 |
|
2,385,096 |
|
(2,519,888) |
|
— |
|
— |
|
(134,792) |
2020 |
|
3,430,708 |
|
— |
|
(30,170) |
|
— |
|
3,400,538 |
|
|
|
|
|
|
|
|
|
|
|
Year |
|
Year-End Fair Value
of Equity Awards
Granted During
Year That Remained
Outstanding and
Unvested as of
Last Day of Year for
Chintu Patel
($) |
|
Change in Fair
Value from Last
Day of Prior Year
to Last Day of Year
of Unvested Equity
Awards for Chintu
Patel
($) |
|
Change in Fair Value
from Last Day of
Prior Year to Vesting
Date of Unvested
Equity Awards that
Vested During Year
for Chintu Patel
($) |
|
Fair Value at Last
Day of Prior Year
of Equity Awards
Forfeited During
Year for Chintu Patel
($) |
|
Total - Inclusion of
Equity Values for
Chintu Patel
($) |
2022 |
|
— |
|
(3,278,019) |
|
— |
|
— |
|
(3,278,019) |
2021 |
|
2,385,096 |
|
(2,519,888) |
|
— |
|
— |
|
(134,792) |
2020 |
|
3,430,708 |
|
— |
|
(30,170) |
|
— |
|
3,400,538 |
|
|
|
Non-PEO NEO Average Total Compensation Amount |
[1] |
$ 2,348,670
|
$ 2,420,041
|
$ 1,922,858
|
Non-PEO NEO Average Compensation Actually Paid Amount |
[1] |
$ (121,995)
|
1,421,310
|
1,985,608
|
Adjustment to Non-PEO NEO Compensation Footnote [Text Block] |
|
Year |
|
Average Summary
Compensation Table
Total for Non-PEO NEOs
($) |
|
Average Exclusion
of Stock Awards and
Option Awards for Non-
PEO NEOs
($) |
|
Average Inclusion of
Equity Values for Non-
PEO NEOs
($) |
|
Average Compensation
Actually Paid to Non-
PEO NEOs
($) |
2022 |
|
2,348,670 |
|
(1,485,810) |
|
(984,855) |
|
(121,995) |
2021 |
|
2,420,041 |
|
(1,505,143) |
|
506,412 |
|
1,421,310 |
2020 |
|
1,922,858 |
|
(1,108,402) |
|
1,171,151 |
|
1,985,608 |
|
|
|
|
|
|
|
|
|
|
|
Year |
|
Average Year-
End Fair Value of
Equity Awards
Granted During
Year That Remained
Outstanding and
Unvested as of Last
Day of Year for Non-
PEO NEOs
($) |
|
Average Change in
Fair Value from Last
Day of Prior Year
to Last Day of Year
of Unvested Equity
Awards for Non-PEO
NEOs
($) |
|
Average Change in
Fair Value from Last
Day of Prior Year
to Vesting Date of
Unvested Equity
Awards that Vested
During Year for Non-
PEO NEOs
($) |
|
Average Fair Value
at Last Day of
Prior Year of Equity
Awards Forfeited
During Year for Non-
PEO NEOs
($) |
|
Total - Average
Inclusion of
Equity Values for
Non-PEO NEOs
($) |
2022 |
|
285,402 |
|
(1,195,845) |
|
(74,412) |
|
— |
|
(984,855) |
2021 |
|
1,086,401 |
|
(581,373) |
|
81,828 |
|
(80,444) |
|
506,412 |
2020 |
|
1,410,331 |
|
(56,431) |
|
(50,813) |
|
(131,936) |
|
1,171,151 |
|
|
|
Compensation Actually Paid vs. Total Shareholder Return [Text Block] |
|
The following chart sets forth the relationship between Compensation
Actually Paid to our PEOs, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company’s cumulative TSR
over the three most recently completed fiscal years.
|
|
|
Compensation Actually Paid vs. Net Income [Text Block] |
|
The following chart sets forth the relationship between Compensation
Actually Paid to our PEOs, the average of Compensation Actually Paid to our Non-PEO NEOs, and our net income during the three most
recently completed fiscal years.
|
|
|
Compensation Actually Paid vs. Company Selected Measure [Text Block] |
|
The following chart sets forth the relationship between Compensation
Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and our Adjusted EBITDA during the three
most recently completed fiscal years.
|
|
|
Total Shareholder Return Vs Peer Group [Text Block] |
|
The following chart compares our cumulative TSR over the three
most recently completed fiscal years to that of the Dow Jones U.S. Select Pharmaceuticals Index over the same period.
|
|
|
Tabular List [Table Text Block] |
|
Tabular List of Most Important Financial
Performance Measures
The following table presents the financial performance measures
that the Company considers to have been the most important in linking Compensation Actually Paid to our PEOs and other NEOs for
2022 to Company performance. The measures in this table are not ranked.
|
Adjusted EBITDA
Stock Price |
|
|
|
|
|
# # # |
|
|
|
|
Total Shareholder Return Amount |
|
$ 41.29
|
99.38
|
94.81
|
Peer Group Total Shareholder Return Amount |
|
123.43
|
129.31
|
114.32
|
Net Income (Loss) |
|
$ (255,000,000)
|
$ 20,000,000
|
$ 69,000,000
|
Company Selected Measure Amount |
|
5.14
|
5.38
|
4.33
|
Measure [Axis]: 1 |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Measure Name |
|
Adjusted EBITDA
|
|
|
Measure [Axis]: 2 |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Measure Name |
|
Stock Price
|
|
|
Non-PEO NEO [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
$ (984,855)
|
$ 506,412
|
$ 1,171,151
|
Non-PEO NEO [Member] | Exclusion Of Stock Awards And Option Awards [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(1,485,810)
|
(1,505,143)
|
(1,108,402)
|
Non-PEO NEO [Member] | Inclusion Of Pension Service Cost [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(984,855)
|
506,412
|
1,171,151
|
Non-PEO NEO [Member] | Adjustment Type 1 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
285,402
|
1,086,401
|
1,410,331
|
Non-PEO NEO [Member] | Adjustment Type 2 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(1,195,845)
|
(581,373)
|
(56,431)
|
Non-PEO NEO [Member] | Adjustment Type 3 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(74,412)
|
81,828
|
(50,813)
|
Non-PEO NEO [Member] | Adjustment Type 4 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
|
(80,444)
|
(131,936)
|
Chirag Patel [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
PEO Total Compensation Amount |
[1] |
5,048,110
|
4,785,116
|
2,320,716
|
PEO Actually Paid Compensation Amount |
[1] |
$ (1,835,706)
|
$ 1,383,918
|
$ 3,422,575
|
PEO Name |
|
Chirag Patel
|
Chirag Patel
|
Chirag Patel
|
Chirag Patel [Member] | PEO [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
$ (3,278,019)
|
$ (134,792)
|
|
Chirag Patel [Member] | PEO [Member] | Exclusion Of Stock Awards And Option Awards [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(3,605,796)
|
(3,266,406)
|
$ (2,298,679)
|
Chirag Patel [Member] | PEO [Member] | Inclusion Of Pension Service Cost [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(3,278,019)
|
(134,792)
|
3,400,538
|
Chirag Patel [Member] | PEO [Member] | Adjustment Type 1 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
|
2,385,096
|
3,430,708
|
Chirag Patel [Member] | PEO [Member] | Adjustment Type 2 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(3,278,019)
|
(2,519,888)
|
|
Chirag Patel [Member] | PEO [Member] | Adjustment Type 3 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
|
|
(30,170)
|
Chirag Patel [Member] | PEO [Member] | Adjustment Type 4 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
|
|
|
Chintu Patel [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
PEO Total Compensation Amount |
[1] |
5,062,732
|
4,798,825
|
2,328,528
|
PEO Actually Paid Compensation Amount |
[1] |
$ (1,821,083)
|
$ 1,397,627
|
$ 3,430,387
|
PEO Name |
|
Chintu Patel
|
Chintu Patel
|
Chintu Patel
|
Chintu Patel [Member] | PEO [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
$ (3,278,019)
|
$ (134,792)
|
$ 3,400,538
|
Chintu Patel [Member] | PEO [Member] | Exclusion Of Stock Awards And Option Awards [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(3,605,796)
|
(3,266,406)
|
(2,298,679)
|
Chintu Patel [Member] | PEO [Member] | Inclusion Of Pension Service Cost [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(3,278,019)
|
(134,792)
|
3,400,538
|
Chintu Patel [Member] | PEO [Member] | Adjustment Type 1 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
|
2,385,096
|
3,430,708
|
Chintu Patel [Member] | PEO [Member] | Adjustment Type 2 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
(3,278,019)
|
(2,519,888)
|
|
Chintu Patel [Member] | PEO [Member] | Adjustment Type 3 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
|
|
(30,170)
|
Chintu Patel [Member] | PEO [Member] | Adjustment Type 4 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
Adjustment to Compensation Amount |
|
|
|
|
Andrew Boyerr [Member] | Non Peo 1 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
PEO Name |
|
Andrew Boyer
|
Andrew Boyer
|
Andrew Boyer
|
Anastasios Konidaris [Member] | Non Peo 1 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
PEO Name |
|
Anastasios Konidaris
|
Anastasios Konidaris
|
Anastasios Konidaris
|
Nikita Shah [Member] | Non Peo 1 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
PEO Name |
|
Nikita Shah
|
Nikita Shah
|
Nikita Shah
|
Joseph Todisco [Member] | Non Peo 1 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
PEO Name |
|
Jason Daly
|
Joseph Todisco
|
Joseph Todisco
|
Todd Branning [Member] | Non Peo 1 [Member] |
|
|
|
|
Pay vs Performance Disclosure [Table] |
|
|
|
|
PEO Name |
|
|
|
Todd Branning
|
|
|